(VOR) Vor Biopharma - Performance -7% in 12m
VOR performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-78.12%
#125 in Peer-Group
Rel. Strength
32.88%
#4986 in Stock-Universe
Total Return 12m
-7.02%
#67 in Peer-Group
Total Return 5y
-97.17%
#158 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 1.74 USD |
| 52 Week Low | 0.15 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 99.57 |
| Buy/Sell Signal +-5 | 1.10 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: VOR (-7%) vs XBI (-10.6%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.17% | 66% | 81.3% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.71% | -10.3% | 137% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-0.83% | -8.8% | 39.9% | 26.4 | 13.9 | 0.96 | 0.60% | 41% |
| BIM PA Biomerieux |
1.94% | 32.9% | 4.38% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
10.9% | 57.2% | 3.4% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
2.27% | -6.62% | -0.06% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
4.14% | 43.8% | -1.58% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
7.68% | 32.4% | 16% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: VOR vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for VOR
| Total Return (including Dividends) | VOR | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 509.20% | 4.69% | 4.33% |
| 3 Months | 38.38% | -2.94% | 8.76% |
| 12 Months | -7.02% | -10.58% | 13.95% |
| 5 Years | -97.17% | -24.51% | 116.91% |
| Trend Score (consistency of price movement) | VOR | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 56% | 30.9% | 79.1% |
| 3 Months | -45.3% | 63.2% | 91.7% |
| 12 Months | -40.7% | -83.8% | 44% |
| 5 Years | -96.7% | -52.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th99.50 | 481.92% | 483.92% |
| 3 Month | %th88.50 | 42.57% | 27.24% |
| 12 Month | %th67.50 | 3.98% | -18.40% |
| 5 Years | %th25.00 | -94.33% | -98.33% |
FAQs
Does Vor Biopharma (VOR) outperform the market?
Yes,
over the last 12 months VOR made -7.02%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.58%.
Over the last 3 months VOR made 38.38%, while XBI made -2.94%.
Performance Comparison VOR vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
VOR vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 338.2% | 504.9% | -20.5% | -21% |
| US NASDAQ 100 | QQQ | 337.5% | 503.9% | -21.7% | -21% |
| German DAX 40 | DAX | 338.8% | 510% | -36.4% | -38% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 339.4% | 506.3% | -17.7% | -25% |
| Hongkong Hang Seng | HSI | 336.9% | 501.8% | -37.9% | -43% |
| India NIFTY 50 | INDA | 338% | 506.8% | -21.7% | -8% |
| Brasil Bovespa | EWZ | 340% | 506.8% | -43.6% | -15% |
VOR vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 336.7% | 503.2% | -26.8% | -33% |
| Consumer Discretionary | XLY | 337.7% | 508.2% | -12.2% | -27% |
| Consumer Staples | XLP | 341.6% | 510.7% | -19.4% | -14% |
| Energy | XLE | 345% | 505.2% | -19% | -4% |
| Financial | XLF | 338.2% | 506.9% | -23.8% | -36% |
| Health Care | XLV | 340.2% | 507.4% | -13.8% | -0% |
| Industrial | XLI | 338.3% | 506.5% | -27.4% | -29% |
| Materials | XLB | 339.5% | 507.9% | -21% | -8% |
| Real Estate | XLRE | 342.5% | 508.8% | -19.5% | -19% |
| Technology | XLK | 337.2% | 501% | -22.5% | -19% |
| Utilities | XLU | 340.3% | 508.9% | -25% | -29% |
| Aerospace & Defense | XAR | 336% | 500.2% | -40.9% | -57% |
| Biotech | XBI | 340.9% | 504.5% | -7.4% | 4% |
| Homebuilder | XHB | 337.7% | 507.3% | -10.8% | -5% |
| Retail | XRT | 341% | 507.7% | -12.8% | -12% |
VOR vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 353.5% | 500% | -15.8% | 1% |
| Natural Gas | UNG | 348% | 512.3% | -21.5% | 1% |
| Gold | GLD | 344.5% | 510.3% | -41.3% | -47% |
| Silver | SLV | 342% | 501.3% | -38.4% | -30% |
| Copper | CPER | 337.1% | 502.4% | -39.3% | -25% |
VOR vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 340.6% | 506.9% | -18.7% | -4% |
| iShares High Yield Corp. Bond | HYG | 341% | 507.6% | -21.3% | -17% |